To send appointment requests to presenters, please click
At Academic Forum, researchers of universities and national/public
institutes will present their latest research results.

Venue : Inside the Exhibition Halls (no pre-registration necessary.)
*Please note that some forum may not have interpretation.
(Honorifics omitted) *Please note that programs are subject to change
Date:May 13 (Wed) 12:45 ~ 13:15     Venue: ACA-6
Evaluation of the antioxidative capacity by the multiple free-radical scavenging (MULTIS) method
Date:May 13 (Wed) 12:45 ~ 13:15     Venue: ACA-1
Generation of platelets from pre-adipocytes
Date:May 13 (Wed) 12:45 ~ 13:15     Venue: ACA-4
Technologies for biodrugs development and approach for drug discovery support
Date:May 13 (Wed) 12:45 ~ 13:15     Venue: ACA-2
A novel recombinant BCG expressed in mammalian cells elicits functional BCG-specific CD8 T cells
Date:May 13 (Wed) 12:45 ~ 13:15     Venue: ACA-5
Development of detective and diagnostic pharmaceuticals for infectious disease and cancer
Date:May 13 (Wed) 12:45 ~ 13:15     Venue: ACA-3
Functional analysis of stress response factor in mouse brain
Date:May 13 (Wed) 13:30 ~ 14:00     Venue: ACA-6
Cell Membrane Devices for Drug Screening and Sensor Applications
Date:May 13 (Wed) 13:30 ~ 14:00     Venue: ACA-1
Novel preservative for cell, organization and organ using ice crystal-controlling material
Date:May 13 (Wed) 13:30 ~ 14:00     Venue: ACA-5
Detection of anti-thrombopoietin antibodies in patients with immune thrombocytopenia
Date:May 13 (Wed) 13:30 ~ 14:00     Venue: ACA-4
Protein ligation technique for drug discovery
Date:May 13 (Wed) 13:30 ~ 14:00     Venue: ACA-2
Towards Advancing Health with Unobtrusive Multimodal Sensors and Efficient Analytics Methods
Date:May 13 (Wed) 14:15 ~ 14:45     Venue: ACA-4
Drug design of Influenza virus.
Date:May 13 (Wed) 14:15 ~ 14:45     Venue: ACA-6
Diagnostic test material for both P. falciparum and P. vivax malaria using antigenic polypeptides
Date:May 13 (Wed) 14:15 ~ 14:45     Venue: ACA-3
The diagnosis of risk for hepatocellular carcinoma by methylation analysis of integrated HBV genome
Date:May 13 (Wed) 14:15 ~ 14:45     Venue: ACA-5
Hinge-deficient IgG Fc fusion proteins
Date:May 13 (Wed) 14:15 ~ 14:45     Venue: ACA-1
Novel injectable biomaterial for bone regeneration composed of salmon milt DNA/protamine complex
Date:May 13 (Wed) 15:00 ~ 15:30     Venue: ACA-5
Regulation of cedar pollen allergy by monoclonal antibody IgG1 Fabs to cedar pollen Cry j1
Date:May 13 (Wed) 15:00 ~ 15:30     Venue: ACA-1
Catalytic Deuterodechlorination of Aryl/Heteroaryl Chlorides
Date:May 13 (Wed) 15:00 ~ 15:30     Venue: ACA-3
Development of a novel gene targeting for prostate cancer treatment.
Date:May 13 (Wed) 15:00 ~ 15:30     Venue: ACA-4
FD-LC-MS/MS proteomic analysis reveals real dynamics of proteins in cells
Date:May 13 (Wed) 15:00 ~ 15:30     Venue: ACA-6
Biomimetic sensor for therapeutic drug monitoring using molecularly imprinted polymers
Date:May 13 (Wed) 15:00 ~ 15:30     Venue: ACA-2
Zonarol Prevents Inflammation in Dextran Sulfate Sodium-Induced Mice Ulcerative Colitis
Date:May 13 (Wed) 15:30 ~ 16:00     Venue: EX-5
Excellent support center for reaction, nanomaterials and biological science by electron microscopy
Date:May 13 (Wed) 15:45 ~ 16:15     Venue: ACA-3
MiRNA-205 inhibits the growth of melanoma cells in vitro and a clinical trial in canine melanoma
Date:May 13 (Wed) 15:45 ~ 16:15     Venue: ACA-5
Proposal of Anti-obesity Drug-lead
Date:May 13 (Wed) 15:45 ~ 16:15     Venue: ACA-6
Extraction and visualization of hepatoma feeding artery from CT during aortography image
Date:May 13 (Wed) 15:45 ~ 16:15     Venue: ACA-1
Activity and perspective of National Center Biobank Network
Date:May 13 (Wed) 15:45 ~ 16:15     Venue: ACA-2
Sublingual immunization protects periodontal disease and atherosclerosis
Date:May 13 (Wed) 15:45 ~ 16:15     Venue: ACA-4
Technical development for antibody drug
Date:May 13 (Wed) 16:30 ~ 17:00     Venue: ACA-4
Search of drug targets in the treatment of cerebral stroke
Date:May 13 (Wed) 16:30 ~ 17:00     Venue: ACA-2
Discovery of novel immunostimulant from cigarette smoke
Date:May 13 (Wed) 16:30 ~ 17:00     Venue: ACA-1
Microbial interaction between oral bacteria and viruses: its implication of intractable diseases
Date:May 13 (Wed) 16:30 ~ 17:00     Venue: ACA-5
New Antimalarial Candidate from Japan
Date:May 13 (Wed) 16:30 ~ 17:00     Venue: ACA-6
Practical Development of Supersensitive Measurement System of Softness by Palpation Mechanics
Date:May 13 (Wed) 16:30 ~ 17:00     Venue: ACA-3
Application of photodynamic therapy using talaporfin sodium to brain tumor treatment
Date:May 14 (Thur) 11:00 ~ 11:30     Venue: ACA-1
Development of vessel that enhances protein crystallization
Date:May 14 (Thur) 11:00 ~ 11:30     Venue: ACA-6
Development about photo-triggered DNA and RNA manipulation
Date:May 14 (Thur) 11:00 ~ 11:30     Venue: ACA-4
next generation zebrafish-based drug discovery and personalized medicine
Date:May 14 (Thur) 11:00 ~ 11:30     Venue: ACA-3
Establishing "Cancer Stem Cell Collection'' from iPS cells
Date:May 14 (Thur) 11:00 ~ 11:30     Venue: ACA-5
Activities for academia originated drug discovery by RIKEN DMP
Date:May 14 (Thur) 11:00 ~ 11:30     Venue: EX-5
Introduction of LED Life Innovation Research Project in The University of Tokushima
Date:May 14 (Thur) 11:00 ~ 11:30     Venue: ACA-2
Characterization of bio-active substances acting on health and youth--Longevity Genes and Health--
Date:May 14 (Thur) 11:45 ~ 12:15     Venue: ACA-6
A interactive tool for drawing a pedigree in genetic counseling
Date:May 14 (Thur) 11:45 ~ 12:15     Venue: ACA-5
Proposal for treatment/ prevension of fatty liver diseases by SOAT2 inhibitors
Date:May 14 (Thur) 11:45 ~ 12:15     Venue: ACA-4
Utilization of bioresources as a drug discovery research tool.
Date:May 14 (Thur) 11:45 ~ 12:15     Venue: ACA-3
Drug metabolism in 3D spheroid ~The application in the metabolism of molecular target drugs~
Date:May 14 (Thur) 11:45 ~ 12:15     Venue: ACA-1
Chemoenzymatic synthesis of homogeneous glycoprotein:glycoengineered trastuzumab
Date:May 14 (Thur) 11:45 ~ 12:15     Venue: ACA-2
Hair growth cycle regulation by fibroblast growth factors
Date:May 14 (Thur) 12:30 ~ 13:00     Venue: ACA-2
Boron-doped Diamond Based Polymer Composites and Its Application for a Novel Dental Treatment Unit
Date:May 14 (Thur) 12:30 ~ 13:00     Venue: ACA-6
A novel diagnostic system for periodontitis
Date:May 14 (Thur) 12:30 ~ 13:00     Venue: ACA-3
Iron control therapy for cancer and inflectional disease
Date:May 14 (Thur) 12:30 ~ 13:00     Venue: ACA-1
The latest activities of our laboratory(RIAS) to realize One Health
Date:May 14 (Thur) 12:30 ~ 13:00     Venue: ACA-4
Increased Oxidative Stress in ALS and the Effect of Edaravone Administration
Date:May 14 (Thur) 13:15 ~ 13:45     Venue: ACA-6
novel estimating portable device and soft of ianalysis of cardiac function
Date:May 14 (Thur) 13:15 ~ 13:45     Venue: ACA-3
Molecularly imprinted drug delivery catrriers that acquire stealth in situ
Date:May 14 (Thur) 13:15 ~ 13:45     Venue: ACA-2
Human disease models in Drosophila and new attempt to screen for candidates of drugs
Date:May 14 (Thur) 13:15 ~ 13:45     Venue: ACA-4
In vivo-like cell-based assay device-Evaluate efficacy & toxicity at physiological conc with 1h!-
Date:May 14 (Thur) 13:15 ~ 13:45     Venue: ACA-5
Design of bio-active nano-clusters toward membrane-targeting nano-medicine
Date:May 14 (Thur) 14:00 ~ 14:30     Venue: ACA-4
Developing a drug screening system for newly identified tumor suppressor pathway and seeds discovery
Date:May 14 (Thur) 14:00 ~ 14:30     Venue: ACA-6
Simultaneous detection of tumor-associated autoantibodies: improvement in diagnostic sensitivity.
Date:May 14 (Thur) 14:00 ~ 14:30     Venue: ACA-2
Production of vinyl monomers by using microbial fermentation
Date:May 14 (Thur) 14:00 ~ 14:30     Venue: ACA-3
Detecting ultra-early cancers a by food dyes and multi-photon laser microscopy
Date:May 14 (Thur) 14:00 ~ 14:30     Venue: ACA-5
New Urinary Biomarkers for Diabetic Nephropathy
Date:May 14 (Thur) 14:00 ~ 14:30     Venue: ACA-1
Application of silkworm-BmNPV bacmid expression system
Date:May 14 (Thur) 14:45 ~ 15:15     Venue: ACA-6
Modulatory mechanisms of pain relief by dietary constituent
Date:May 14 (Thur) 14:45 ~ 15:15     Venue: ACA-1
The development of a novel affinity tag system for protein purification.
Date:May 14 (Thur) 14:45 ~ 15:15     Venue: ACA-5
Development of new treatments on oxaliplatin-induced neuropathy
Date:May 14 (Thur) 14:45 ~ 15:15     Venue: ACA-3
A role of SNX1 in the regulation of EGFR/MET endocytosis and signaling pathway in lung cancer cells
Date:May 14 (Thur) 14:45 ~ 15:15     Venue: ACA-2
Synthesis of Tailor-made Ceramic Nanocrystals towards Bio-Medical Applications
Date:May 14 (Thur) 14:45 ~ 15:15     Venue: ACA-4
Cyclin-dependent kinase 5: a potential therapeutic target for neurodegenerative diseases
Date:May 14 (Thur) 15:30 ~ 16:00     Venue: ACA-6
B6 background congenic strains carrying EL mice-derived epilepsy prone quantitative trait loci.
Date:May 14 (Thur) 15:30 ~ 16:00     Venue: ACA-4
In silico drug discovery with FAMS and chooseLD
Date:May 14 (Thur) 15:30 ~ 16:00     Venue: ACA-2
Fluorescent probes for asbestos
Date:May 14 (Thur) 15:30 ~ 16:00     Venue: EX-5
Metabolomics based approach to discriminate between uropathogenic E. coli isolates
Date:May 14 (Thur) 15:30 ~ 16:00     Venue: ACA-5
Development of novel DNA-aptamers rised against RAGE in several disorders
Date:May 14 (Thur) 15:30 ~ 16:00     Venue: ACA-1
Non-column and simple purification of active proteins expressed as fusions with association tags
Date:May 14 (Thur) 15:30 ~ 16:00     Venue: ACA-3
Cancer treatment with recombinant anaerobic bacteria
Date:May 14 (Thur) 16:15 ~ 16:45     Venue: ACA-3
We require the company to develop anti-KK-LC-1 drugs/diagnostics for cancer
Date:May 14 (Thur) 16:15 ~ 16:45     Venue: ACA-5
Near-infrared chemiluminescent agent for superoxide
Date:May 14 (Thur) 16:15 ~ 16:45     Venue: ACA-4
Development of therapeutic drug by screening of peptide display libraries
Date:May 14 (Thur) 16:15 ~ 16:45     Venue: ACA-1
Growth of high quality crystals for structural analysis and crystal polymorphism screening
Date:May 14 (Thur) 16:15 ~ 16:45     Venue: ACA-2
Diagnostic and Therapeutic Glycoconjugates
Date:May 14 (Thur) 16:15 ~ 16:45     Venue: ACA-6
A potential therapeutic role of LRP1 against neurodegenerative disorders
Date:May 14 (Thur) 17:00 ~ 17:30     Venue: ACA-2
Development of Human Machine Interface Using Bio-signals (EEG/EOG/EMG)
Date:May 14 (Thur) 17:00 ~ 17:30     Venue: ACA-5
Designing functional peptides: Discovery of a miniature enzyme that digest amyloid fibrils
Date:May 14 (Thur) 17:00 ~ 17:30     Venue: ACA-1
Slow release of cytokines from insect-derived protein micro-crystals
Date:May 14 (Thur) 17:00 ~ 17:30     Venue: ACA-6
Development and application of Drosophila model for human ALS
Date:May 15 (Fri) 11:00 ~ 11:30     Venue: ACA-6
Importance of detecting highly pathogenic oral bacteria
Date:May 15 (Fri) 11:00 ~ 11:30     Venue: ACA-4
Photoresponsive Cell Migration Assay
Date:May 15 (Fri) 11:00 ~ 11:30     Venue: ACA-1
Tools from NIG:transposon and zebrafish
Date:May 15 (Fri) 11:00 ~ 11:30     Venue: ACA-3
Discovery of a new diagnostic biomarker by implantation of human cancer cells into animals
Date:May 15 (Fri) 11:00 ~ 11:30     Venue: ACA-5
Cancer Immunotherapy with blocking of immune-exhaustion
Date:May 15 (Fri) 11:00 ~ 11:30     Venue: ACA-2
High-speed Super-resolution Live Imaging Microscope to Visualize Intracellular Molecular Dynamics
Date:May 15 (Fri) 11:45 ~ 12:15     Venue: ACA-3
Anti-podoplanin neutralizing antibodies exhibiting anti-tumor and anti-metastatic abilities
Date:May 15 (Fri) 11:45 ~ 12:15     Venue: ACA-6
For discovery of novel bioactive compounds -Attraction of Kitasato microbial liblary-
Date:May 15 (Fri) 11:45 ~ 12:15     Venue: ACA-4
Nano-pathophysiology: Intractability due to structure in disease foci limiting drug delivery
Date:May 15 (Fri) 11:45 ~ 12:15     Venue: ACA-5
Activities and Themes/Projects for drug discovery by RIKEN DMP
Date:May 15 (Fri) 11:45 ~ 12:15     Venue: ACA-1
A practical fluorogenic substrate for high throughput screening of GST inhibitors
Date:May 15 (Fri) 11:45 ~ 12:15     Venue: ACA-2
Visualization of sialidase activity with a novel fluorescent sialidase substrate
Date:May 15 (Fri) 12:30 ~ 13:00     Venue: ACA-2
In vivo retinal hypoxia imaging for diabetic retinopathy and macular degeneration
Date:May 15 (Fri) 12:30 ~ 13:00     Venue: ACA-3
A novel antitumor compound with dual targeting of AKT and ERK pathways
Date:May 15 (Fri) 12:30 ~ 13:00     Venue: ACA-4
Disease-modifying drugs targeting new action sites for Alzheimer's disease
Date:May 15 (Fri) 12:30 ~ 13:00     Venue: ACA-5
Novel vaccine vector to induce mucosal immune responses
Date:May 15 (Fri) 12:30 ~ 13:00     Venue: ACA-1
Research Supports at Okayama Medical Innovation Center
Date:May 15 (Fri) 12:30 ~ 13:00     Venue: ACA-6
Potential of microbial library
Date:May 15 (Fri) 13:15 ~ 13:45     Venue: ACA-3
Curcumin analog -A new class of anti-cancer agent, its development and future-
Date:May 15 (Fri) 13:15 ~ 13:45     Venue: ACA-2
Establishment of a method isolating the certain fibroblasts to fabricate a functional cardiac tissue
Date:May 15 (Fri) 13:15 ~ 13:45     Venue: ACA-1
Sensitive biosensing platform based on artificial bio-membranes
Date:May 15 (Fri) 13:15 ~ 13:45     Venue: ACA-5
Effect of inosine on prevention of cognitive deficit and depression.
Date:May 15 (Fri) 13:15 ~ 13:45     Venue: ACA-4
Research Human Cord Blood Bank (NBRP)
Date:May 15 (Fri) 13:15 ~ 13:45     Venue: ACA-6
High throughput applications of paper-based fluidic device by active solution sending
Date:May 15 (Fri) 14:00 ~ 14:30     Venue: ACA-4
Development of a new retinal angiogenesis treatment
Date:May 15 (Fri) 14:00 ~ 14:30     Venue: ACA-1
Production and physiological function of novel small proteins in the brain
Date:May 15 (Fri) 14:00 ~ 14:30     Venue: ACA-5
Evaluation of functional foods by global gene expression analysis
Date:May 15 (Fri) 14:00 ~ 14:30     Venue: ACA-6
Introduction of National Institute of Genetics
Date:May 15 (Fri) 14:00 ~ 14:30     Venue: ACA-3
Development of antibodies for diagnosis and treatment of tumors and chronic diseases in dog
Date:May 15 (Fri) 14:00 ~ 14:30     Venue: ACA-2
Discovery and development of far red-sensing and fluorescent proteins
Date:May 15 (Fri) 14:45 ~ 15:15     Venue: ACA-5
Risk assessment and thestrategies for prevention of Mycotoxin in food safety
Date:May 15 (Fri) 14:45 ~ 15:15     Venue: ACA-3
Study of New Antitumor Drugs Based on Peroxides
Date:May 15 (Fri) 14:45 ~ 15:15     Venue: ACA-1
Mouse models of pulmonary fibrosis, kidney fibrosis and COPD
Date:May 15 (Fri) 14:45 ~ 15:15     Venue: ACA-2
Perfusion technology for cell and organ transplantation in Regenerative medicine era
Date:May 15 (Fri) 14:45 ~ 15:15     Venue: ACA-4
Chemical Synthesis of Axially Chiral Natural Products
Date:May 15 (Fri) 14:45 ~ 15:15     Venue: ACA-6
Application study of IR free electron laser towards therapy of protein aggregation diseases
Date:May 15 (Fri) 15:30 ~ 16:00     Venue: ACA-2
Noninvasive discrimination of cancer cell from normal cell on a clear plate by phase shift analysis
Date:May 15 (Fri) 15:30 ~ 16:00     Venue: ACA-6
Deployment of a new fluorescent dye to the medical field
Date:May 15 (Fri) 15:30 ~ 16:00     Venue: ACA-3
Discovery of novel radical reaction and preparation of anticancer natural products
Date:May 15 (Fri) 15:30 ~ 16:00     Venue: ACA-4
Identification of epigenetic drug targets using locus-specific chromatin immunoprecipitation
Date:May 15 (Fri) 15:30 ~ 16:00     Venue: ACA-5
The birth of quail chicks after intracytoplasmic sperm injection
▲PAGE UP